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ABSTRACT
BACKGROUND: Orthostatic Hypotension is a serious 
and common complication of diabetes mellitus.   
AIMS: To determine the prevalence and risk factors of 
Orthostatic Hypotension in type 2 diabetic patients in a 
diabetes mellitus clinic in Enugu South-East Nigeria.
METHOD AND MATERIALS: A structured 
questionnaire was administered to the eligible and 
consenting seventy type 2 diabetes mellitus patients. 
The supine and erect blood pressures of each patient 
were recorded. The patients with Orthostatic 
Hypotension were compared with those without 
Orthostatic Hypotension for different clinical and 
biochemical parameters. 
STATISTICAL ANALYSIS USED: The data was 
analyzed using Statistical Package for Social Sciences 
(SPSS) version 19 software. Odds ratio was calculated 
for the presence of Orthostatic Hypotension amongst the 
variables and p-value <0.05 was considered statistically 
significant.
RESULTS: The prevalence of Orthostatic Hypotension 
in type 2 diabetic patients was 23.3%. Orthostatic 
Hypotension had statistically significant association 
with the presence of peripheral neuropathy, retinopathy 
and proteinuria. 
CONCLUSIONS: Orthostatic Hypotension is a 
common complication in type 2 diabetes mellitus 
patients seen at Enugu. It is recommended that 
measurement of erect and supine blood pressures should 
be part of the standard care of type 2 diabetic patients.
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Enugu, Nigeria
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INTRODUCTION
Diabetes mellitus (DM) refers to a group of common 
metabolic disorders that share the phenotype of 
1hyperglycaemia . It currently assumes a pandemic 
status, with a global prevalence of 366million in 2011 
2  nd
and an expected rise to 552million by 2030 . It is the 2  
3
most common non-communicable disease in Nigeria.
Autonomic dysfunction is a serious and common 
4
complication of DM.   Orthostatic hypotension (OH) is 
one of the manifestations of autonomic dysfunction and 
5
it carries a high risk of cardiovascular mortality . 
OH is defined as a fall in blood pressure (i.e., =20 mmHg 
for systolic or/and =10 mmHg for diastolic blood 
pressure) in response to change from supine to erect 
6posture .  In patients with diabetes, OH is usually due to 
damage to the efferent sympathetic vasomotor fibers, 
which leads to a decrease in splanchnic, cutaneous and 
7total vascular resistance.  
Normally, in response to postural change, there is an 
increase in plasma norepinephrine. For individuals with 
orthostatic hypotension, there may be a reduction in this 
8
response relative to the fall in blood pressure.  
Diminished cardiac acceleration and cardiac output, 
particularly in association with exercise, may also be 
9,10
important in the presentation of this disorder.  Less 
frequently, there is a rise in norepinephrine that may be 
11,12due to low blood volume or reduced red cell mass.  
Frequently, there are fluctuations in the degree of 
orthostatic hypotension. This may reflect postprandial 
blood pooling, the hypotensive role of insulin, and 
changing patterns of fluid retention due to renal failure 
13,14
or congestive heart failure.
Patients with OH typically present with lightheadedness 
and presyncopal symptoms such as dizziness, weakness, 
fatigue, and visual blurring. Neck pain also may be due 
to orthostatic hypotension. Many patients, however, 
remain asymptomatic despite significant falls in blood 
15
pressure.  If the cause of orthostatic hypotension is 
cardiac autonomic neuropathy (CAN), treatment goals 
should not only consist of therapies to increase the 
standing blood pressure, balanced against preventing 
16hypertension in the supine position , but should also 
provide education to patients so that they avoid 
situations (e.g., vasodilation from hot showers) that 
result in the creation of symptoms. Such symptoms can 
result in injuries from falling. Cardiovascular autonomic 
function testing may help differentiate CAN from other 
causes of weakness, lightheadedness, dizziness, or 
fatigue and promote appropriate therapeutic 
17intervention.  
The prevalence of orthostatic hypotension in diabetic 
subjects varies from 8.2% to 43%, depending on the 
18,19
diagnostic criterion and study subject selection.  
There is paucity of data on OH in Nigeria. Thus, it 
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became necessary to determine the prevalence and risk 
factors of OH in Type 2 DM patients in a Diabetes clinic 
in Enugu South-East Nigeria.
M E T H O D  A N D  M A T E R I A L S                                                                                                   
This was a cross-sectional, hospital based, descriptive 
and analytical study carried out in the DM Clinic of 
University of Nigeria Teaching Hospital (UNTH) 
Enugu between July and October 2011. UNTH receives 
referral from the states within south-east zone of Nigeria 
(Enugu, Ebonyi, Abia, Anambra, and Imo states) and the 
neighboring states (Kogi, Benue, Delta, and Cross-
River States).
A sample size of 70 subjects was calculated using the 
WHO formula for sample size determination in a finite 
20population.  Eligible and consenting type 2 diabetes 
mellitus patients of both sexes between the ages of 15-
70yrs were drawn using systematic random sampling 
method ie first of every ten (10) patients seen at the 
UNTH diabetic clinic from July to October 2011
Ethical clearance was obtained from ethics committee of 
the UNTH Enugu.
A written consent was obtained after a detailed 
explanation of the procedures involved. For those that 
were illiterates, thumb printing was used.
The patients with the following conditions were 
excluded from the study:
• Chronic alcoholics with alcohol consumption 
of >120gm/wk
• Age >70yrs or <15yrs
• History of prolonged recumbency
• Use of drugs known to affect autonomic nerves 
functions e.g. Beta blockers, tricyclic 
antidepressants, isoniazid, oral nitrates.
• Chronic kidney disease (eGFR<60ml/min)
• Congestive cardiac failure
• Parkinson disease 
• Leprosy 
The subjects were allowed to withdraw verbally.
A structured pre-tested questionnaire was administered 
to the eligible and consenting patients by the 
investigator. It assessed history of diabetes mellitus 
including duration of DM, level of control and 
symptoms of autonomic neuropathy like postural 
dizziness, erectile dysfunction, bowel habit, abnormal 
sweating etc. 
Anthropometric data (weight, height) were obtained 
using weighing scale and measuring tape. Body mass 
index (BMI) was calculated and obesity was defined as 
21  
BMI of =30.  
Orthostatic hypotension was assessed by measuring the 
supine blood pressure of the subjects after 10 minutes of 
rest, with the cuff of the mercury sphygmomanometer 
applied to the right upper arm. The approximate systolic 
BP was obtained by palpation. Then, the cuff was 
deflated and re-inflated to about 10mmHg above the 
approximate systolic BP. Phases I and V korotkoff's 
sounds were used as systolic and diastolic BP 
respectively. The subjects then stood up and the BP was 
recorded after 2 minutes.
If standing was followed by a reduction of systolic BP of 
= 20mmHg and/ or diastolic BP of = 10mmHg, 
6
orthostatic hypotension was said to be present.
A thorough neurological examination was carried out in 
a quiet room to assess functions of the higher centres, 
cranial nerves, motor and sensory systems.  
Peripheral neuropathy was defined by the presence of 
Loss of ankle jerk, light touch sensation, vibration sense 
21or proprioception.
Also retinopathy was assessed for using a Welch-Allyn® 
ophthalmoscope after pupillary dilatation with 1% 
phenylephrine.
Venous blood was collected using a 10ml syringe and 
used as follows for laboratory tests;
• 5ml for serum creatinine assay using  Jaffe's 
method and
• 5ml for serum fasting lipid profile estimation 
using enzymatic method. Both were read using 
colorimetry.
Capillary blood was collected through finger prick for 
fasting blood glucose (FBG) estimation using Accu-
Chek® advantage glucometer. FBG values of 110mg/dl 
and above were regarded as poor control. 
Clean catch mid-stream urine was collected for 
proteinuria using dipstick method.
DATA ANALYSIS
The data were analysed using Statistical Package for 
Social Sciences (SPSS) version 19 software. Qualitative 
data were described as proportions and percentages 
while quantitative data were reported as mean and 
standard deviations. Odds ratio (OR) was used in the 
assessment of associations between OH and the 
variables. A p- value <0.05 was considered statistically 
significant. 
RESULTS
A total of 150 type 2 DM patients were screened for the 
study. Seventy (70) of them were studied, having met 
inclusion criteria. This was made up of 27 (38.6%) males 
and 43 (61.4%) females. The mean age of patients was 
55.76±8.62years. The age distribution of patients is 
shown in figure 1.
176
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The mean duration of DM was 7.67yrs±7.87yrs. Fifty 
three patients (76%) and 17 (24%) have had DM < 10yrs 
and > 10years respectively.
The most common and least common symptom of 
autonomic neuropathy noted in the patients were 
abnormal sweating pattern (37.1%) and nocturnal 
diarrhoea (10%). Other symptoms include erectile 
dysfunction, postural dizziness, and constipation as 
shown in table 1. 
Peripheral neuropathy was present in 14 (18.6%) 
patients. The details of examination findings were 
shown in figure 2. 
The prevalence of OH in type 2 DM patients was      
16(23.3%).  
The prevalence of OH increased with increasing age as 
shown in table 2.
Table 2: The age distribution of OH
Table 1: Symptoms of autonomic dysfunction in patients  
Symptoms of DAN                                        Patients       
n(%)         
Abnormal sweating pattern                              26(37.1)       
Erectile dysfunction (N=27)                            20(74.1)       
Postural dizziness                                             18(25.7)       
Constipation                                                     13(18.3)       
Nocturnal  diarrhoea                                            7(10.0)          
 
Age range                                                 OH present 
    years                                                          n(%) 
  <40(N=5)           0(0)  
 41- 50 (N=11)            2(20) 
  51- 60(N=32)                                                8(25) 
61-70 (N=22)                                                6(27) 
The analytic data were shown in tables 3, 4 and 5.  
Table 3: Association of demographic factors and level of DM control with OH
Variables          OH Present    OH Absent  OR(95% CI)       p-value           
                             









                       
10(20)        
      
38(80)          0.70(0.22-
 
2.26) >0.05
=60                  
     
6(27)         
       




Male                    5(19)       
         
22(81)  




Female                 11(26)      





1-10years    
          
12(23)        
      
41(77)  




> 10years                4(24)          






<110                         4(29)            
 
10(71)  
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DISCUSSION  
Autonomic dysfunction is a serious and common 
4complication of DM.  Orthostatic hypotension (OH) is 
one of the manifestations of autonomic dysfunction and 
5it carries a high risk of cardiovascular mortality.  It is 
associated with several diagnoses, and symptoms, 
including lightheadedness soon after standing, an 
increased rate of falls, and a history of myocardial 
22,23
infarction or transient ischemic attack and stroke.
The sex ratio of 0.65 reported in this study is in 
24agreement with a recent hospital based study  but not 
25,26with some that reported 1.02.  The difference could be 
from different sampling techniques applied in the 
studies. The former used systematic sampling technique 
while the latter used quota sampling technique. The 
more preponderance of females in this study may 
suggest better health seeking behaviour of female 
patients considering equal sex distribution of type 2 
1
DM.   
The mean age of 55.76±8.62years reported in this study 
26closely approximates report of Odusan  which was 
61.73±9.78years though some studies reported lower 
24,25
mean age.  The difference is because the former 
studied only type 2 DM patients while the later studied 
both type 1 and type DM patients with attendant lower 
mean age.. 
The prevalence of OH in this study was 23.3% and it is in 
agreement with some hospital based studies.  Shafig et 
24 27al  and Jin Shung et al  reported 26% and 28.4% 
respectively which are comparable with this study. 
However this is much less than that mentioned in 
literature for the indoor patients in spite of the fact that 
28,29
these patients were diabetic as well.  This is probably 
due to comparatively younger age group in this study 
(mean age 55.8 vs. 80 years).
The prevalence of OH in male and female patients were 
19% and 26% respectively and it is in agreement with 
30
the report of Germaine CV et al.  The higher female 
prevalence of OH could be related to the BP lowering 
31effects of female sex hormones.  
The symptoms of autonomic neuropathy observed in 
this study include abnormal sweating pattern, erectile 
dysfunction (ED), postural dizziness, nocturnal 
diarrhoea and constipation in descending order of 
frequency. None of the above symptoms had significant 
statistical association with OH. This is related to the fact 
that they could be caused by other factors other than 
autonomic neuropathy like drugs, and sepsis. Thus, 
above symptoms could not be used to predict the 
presence of OH. 
Erectile dysfunction was noted in 74.1% of males in this 
study and it is higher than 7% reported by Abbasher et 
32al.  This difference could be that the former reported for 
males while the later reported for total sample with 
women inclusive. Also sexual history is sensitive and 
could cause embarrassment amongst patients. This 
could make interviewers reluctant in getting proper 
3 3sexual history.  Furthermore, multifactorial 
pathogenesis of ED could have contributed in its high 
frequency. The absence of significant association 
between ED and OH could have resulted from other 
aetiologies of ED like use of anti-hypertensive drugs, 
vascular disease, metabolic factors, malnutrition, 
endocrine disorders, psychogenic factors, and use of 
anti-diabetic drugs.
There was no significant association between 
hypertension and OH. This is not in agreement with 
Shafiq et al who reported significant association 
24   
between hypertension and OH. The difference could 
be due to the difference in the study populations. 
DM retinopathy, proteinuria and somatic peripheral 
neuropathy all had significant statistical association 
with OH. This is due to the fact that they all have 
common aetiology which is microangiopathy from 
34-36effect of chronic hyperglycaemia.
The frequency of OH progressively increased with 
increasing age of the patients in this study. Those with 
Table 4: Association of symptoms of DAN with OH
Variables           OH Present OH Absent  OR(95%CI)       p-value       
Postural dizziness 5(28) 13(62)  1.43(0.42- 4.89) >0.05
Abnormal sweating  9(35) 17(65)   2.79(0.89- 8.77)  >0.05
Erectile dysfunction 3(15) 17(85)      0.50(0.17- 2.00) >0.05




        
4(57)           2.88(0.57- 14.53) >0.05   
 
Constipation        
      
5(38) 
        
8(62)   
        




Table 5: Association of co-morbidities with OH
 
 
Variables       





Absent    
   
OR(95%CI)      p-value   
                              







     
9(16)  
        
46(84)




Obesity           
    
6(11)   
       
49(89) 
           
0.06(0.02- 0.24) >0.05
Retinopathy  
    
10(40)  
      
15(60) 
           
4.33(1.34- 14.02)     <0.05




          
16(67)  
          
2.38(0.76- 7.43) >0.05
Proteinuria   
    
12(63)
        
7(37)     
        
20.14(5.06- 80.26)    <0.05
Peripheral
         
10(71)
        
4(29)
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age <40years had the frequency of 0% while those 
between 61 and 70years had 27%. This association 
could be derived from the fact that older patients would 
have had DM for longer duration. Also, old age is an 
independent risk factor for OH in the absence of DM due 
37
to age-related neuropathy and other co-morbidities.  
In conclusion, the prevalence of OH is high amongst 
type 2 DM patients in south-east Nigeria. Retinopathy, 
proteinuria and somatic peripheral neuropathy had 
statistically significant association with OH. It is 
recommended that erect and supine BP measurement 
should be part of routine assessment of type 2 DM 
patients especially when above complications are 
present. There is need for more collaborative multi-
centre study on OH in order to define the exact global 
burden.
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